Literature DB >> 12394689

Screening for prostate cancer in high risk populations.

William J Catalona1, Jo Ann V Antenor, Kimberly A Roehl, Judd W Moul.   

Abstract

PURPOSE: Black men and men with a family history of prostate cancer are at higher risk for this disease and may have an earlier age of onset. Consequently, screening at a younger age has been recommended for high risk men, however, there are limited data on actual screening results in young, high risk populations.
MATERIALS AND METHODS: In men 50 years old or older we compared screening results in 1,224 black men, 1,227 men with a positive family history and 63 men who were both with those of 15,964 nonblack men with no known family history. In high risk men in their forties we also evaluated the percent with abnormal screening tests, the positive predictive value of screening tests, cancer detection rates and the prognostic features of tumors detected.
RESULTS: In men 50 years old or older prostate cancer detection rates were 6.4% for controls compared with 10.3%, 10.5% and 17.5%, respectively, for the high risk groups. Among high risk men screened in their forties 8% had suspicious screening tests and approximately 55% who underwent a biopsy had cancer detected. Of tumors detected 80% were organ confined and all but 1 were of moderate Gleason grade 5 years old or older. Only 1 tumor (7%) fulfilled the published criteria for a possibly harmless cancer.
CONCLUSIONS: Black men and men with a family history of prostate cancer are at a 75% to 80% higher risk for prostate cancer. On initial screening of high risk men in their fourth decade only 8% have positive screening tests; however, approximately 55% of these men have tumors, most of which are medically important with favorable prognostic features.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394689     DOI: 10.1097/01.ju.0000033320.15267.a6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.

Authors:  Lucinda Hughes; Fang Zhu; Eric Ross; Laura Gross; Robert G Uzzo; David Y T Chen; Rosalia Viterbo; Timothy R Rebbeck; Veda N Giri
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

2.  Predictive medicine in urology.

Authors:  Bernd J Schmitz-Dräger; Nuria Malats; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-18       Impact factor: 4.226

3.  Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project.

Authors:  Linda Fleisher; Stacy N Davis; Laura Gross; Loretta Bagden; Debra Zakrzewski; Evelyn González; Venk Kandadai; Cheryl Rusten; Jerilyn Baskett; Elias Obeid; Veda N Giri
Journal:  J Cancer Educ       Date:  2016-03       Impact factor: 2.037

4.  Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.

Authors:  Veda N Giri; Karen Ruth; Lucinda Hughes; Robert G Uzzo; David Y T Chen; Stephen A Boorjian; Rosalia Viterbo; Timothy R Rebbeck
Journal:  BJU Int       Date:  2010-08-24       Impact factor: 5.588

5.  "It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer.

Authors:  Elizabeth K Bancroft; Elena Castro; Audrey Ardern-Jones; Clare Moynihan; Elizabeth Page; Natalie Taylor; Rosalind A Eeles; Emma Rowley; Karen Cox
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

6.  Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.

Authors:  Elizabeth Handorf; Nicole Crumpler; Laura Gross; Veda N Giri
Journal:  J Genet Couns       Date:  2013-12-07       Impact factor: 2.537

7.  Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history.

Authors:  M E Wood; B S Flynn; A Stockdale
Journal:  Public Health Genomics       Date:  2013-01-17       Impact factor: 2.000

8.  Substantial family history of prostate cancer in black men recruited for prostate cancer screening: results from the Prostate Cancer Risk Assessment Program.

Authors:  Kathleen Mastalski; Elliot J Coups; Karen Ruth; Susan Raysor; Veda N Giri
Journal:  Cancer       Date:  2008-11-01       Impact factor: 6.860

9.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

10.  Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.

Authors:  J Athene Lane; Joanne Howson; Jenny L Donovan; John R Goepel; Daniel J Dedman; Liz Down; Emma L Turner; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2007-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.